新生學校財團法人新生醫護管理專科學校圖書館 |

Antimicrobial resistance = beyond the breakpoint /

紀錄類型:	書目-電子資源 : 單行本
正題名/作者:	Antimicrobial resistance/ volume editor, J. Todd Weber.
其他題名:	beyond the breakpoint /
其他作者:	Weber, J. Todd.
出版者:	Basel :S. Karger, : 2010,
面頁冊數:	1 online resource :ill. (some col.) :
附註:	When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
標題:	Drug Resistance, Microbial. -
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=253645
ISBN:	9783805593243

Antimicrobial resistance = beyond the breakpoint /
Antimicrobial resistancebeyond the breakpoint /[electronic resource] :volume editor, J. Todd Weber. - Basel :S. Karger,2010 - 1 online resource :ill. (some col.) - Issues in infectious diseases,v. 61662-3819 ;. - Issues in infectious diseases ;v. 6..

When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens

Includes bibliographical references and indexes.

Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections.

ISBN: 9783805593243Subjects--Topical Terms:

322642
Drug Resistance, Microbial.

LC Class. No.: QR177 / .A5855 2010

Dewey Class. No.: 616.9/041

National Library of Medicine Call No.: 2010 D-858

Antimicrobial resistance = beyond the breakpoint /
LDR:02462cmm a2200265 a 4500 001 166061
003 SZ-BaSKA
005 20110603112119.0
006 m d
007 cr cn|||||||||
008 160302s2010 sz a ob 001 0 eng d
020 $a 9783805593243
035 $a 253645
040 $a szbaska
050 0 0 $a QR177 $b .A5855 2010
060 0 0 $a 2010 D-858
060 1 0 $a QW 45 $b A6306 2010
082 0 0 $a 616.9/041 $2 22
245 0 0 $a Antimicrobial resistance $h [electronic resource] : $b beyond the breakpoint / $c volume editor, J. Todd Weber.
260 $a Basel : $c 2010 $b S. Karger,
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Issues in infectious diseases, $x 1662-3819 ; $v v. 6
500 $a When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
504 $a Includes bibliographical references and indexes.
520 $a Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections.
650 1 2 $a Drug Resistance, Microbial. $3 322642
650 0 $a Drug resistance in microorganisms. $3 87317
700 1 $a Weber, J. Todd. $3 322641
830 0 $a Issues in infectious diseases ; $v v. 6. $3 322640
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=253645